Tissue macrophages in many adult organs originate from yolk sac (YS) progenitors, which invade the developing embryo and persist by means of local self-renewal. However, the route and characteristics of YS macrophage trafficking during embryogenesis are incompletely understood. Here we show the early migration dynamics of YS-derived macrophage progenitors in vivo using fate mapping and intravital microscopy. From embryonic day 8.5 (E8.5) CX 3 CR1+ pre-macrophages are present in the mouse YS where they rapidly proliferate and gain access to the bloodstream to migrate towards the embryo. Trafficking of premacrophages and their progenitors from the YS to tissues peaks around E10.5, dramatically decreases towards E12.5 and is no longer evident from E14.5 onwards. Thus, YS progenitors use the vascular system during a restricted time window of embryogenesis to invade the growing fetus. These findings close an important gap in our understanding of the development of the innate immune system.
M acrophages are important effectors of innate immunity. They have a critical function in organ development, maintenance of tissue homeostasis and host protection during infection 1 . Furthermore, they have distinct functions in chronic inflammatory diseases such as atherosclerosis, metabolic disorders and cancer [2] [3] [4] [5] .
Historically, macrophages were believed to originate exclusively from bone marrow (BM)-derived monocytes after their recruitment to tissues. However, first macrophage progenitors develop in the YS, the first site of hematopoiesis in mammals 6 . Fate mapping analyses and lineage tracing experiments have indicated that tissue macrophages in many organs are of early embryonic origin [7] [8] [9] [10] [11] . Macrophages have been proposed to develop in the YS in two successive waves. First, primitive macrophage progenitors appear around E7.25 in the YS and predominantly infiltrate the brain after the onset of circulation 7, [12] [13] [14] . Second, multipotent erythro-myeloid progenitors (EMP) develop from E8.25 onwards and are a major source of tissue resident macrophages 6, 15, 16 . Substantially later, starting from E10.5, hematopoietic stem cells (HSC) arise in the aortogonado-mesonephros (AGM) region and migrate to the liver to initiate fetal definitive hematopoiesis, which later shifts to the BM [17] [18] [19] . In adult life, monocytes and other short-lived myeloid cells are continuously replaced, whereas tissue macrophages can self-renew and persist independently of definitive BM hematopoiesis for prolonged periods of time, potentially throughout life 8, 16, 20 . However, even though macrophage trafficking during early embryonic development is a prerequisite for establishing this important component of the innate immune system, the kinetics of this process have not been defined.
EMPs are characterized by expression of the receptor tyrosine kinase KIT as well as the macrophage colony-stimulating factor 1 receptor (CSF1R). Subsequent differentiation into premacrophages is indicated by expression of the fractalkine receptor CX 3 CR1, whereas mature tissue resident macrophages additionally express F4/80 12, [21] [22] [23] . Thus, these markers allow genetic labeling and visualization of macrophage progenitors early during embryonic development.
In this study, we present in vivo data of EMP and premacrophage trafficking and proliferation in mouse YS and embryo. We identify a restricted time frame in which these cells travel from the YS to infiltrate the embryo via the bloodstream before becoming phenotypically mature macrophages within their tissue of residence.
Results

Intravital microscopy of YS macrophages.
To visualize the early development of macrophages in the mouse YS (Fig. 1a-f ) and their trafficking to the embryo (Figs. 1g-k and 2a-f) we established an in vivo imaging strategy (Fig. 1b, c ; Methods).
We first took advantage of Cx 3 cr1 GFP/+ knock-in mice to visualize pre-macrophages and macrophages 21 . Green fluorescent protein (GFP)-labeling in Cx 3 cr1 GFP/+ embryos corresponds to the CX 3 CR1+ CD45+ c-KIT-("A3-like") population previously characterized in vitro, while other hematopoietic lineages are not labeled ( Supplementary Fig. 1a-c) 8, 12 . CX 3 CR1+ positive cells were not detectable in the YS by epifluorescence microscopy at E8.5; however, a rapidly expanding population of CX 3 CR1+ premacrophages appeared shortly thereafter (Fig. 1d) . Macrophage numbers per area increased significantly in tissues during embryogenesis. Maximum cell density was approximately 100 cells per microscopic field (400× 400 µm) in the YS and reached a plateau by E12.5 with stable cell densities thereafter (Fig. 1d, e) . In parallel to the increase in cell numbers, CX 3 CR1+ premacrophages underwent morphological changes from spherical shape to mature cells with multiple dendrites (Fig. 1d) potentially engaging in direct cell-to-cell contacts, as it is typically found in adult tissues 24 . Moreover, pre-macrophages appeared partially associated with vascular structures (Fig. 1f and Supplementary  Fig. 1d ) and the first detection of CX 3 CR1+ pre-macrophages was temporally correlated with the formation of a dense vascular network (Fig. 1d, f and Supplementary Fig. 1d , e).
Trafficking of YS macrophage progenitors via the bloodstream. To date two alternate routes have been postulated of how macrophage progenitors enter the embryo, trans-tissue migration or trans-vascular trafficking via the bloodstream 7, 13, 22, [25] [26] [27] . To address these two hypotheses, we directly imaged the trafficking routes of YS macrophage progenitors during embryogenesis using intravital microscopy. We observed CX 3 CR1+ pre-macrophages entering the YS vasculature (Fig. 1g, Supplementary Movies 1, 2) and traveling towards the embryo (Fig. 1h, i , Supplementary  Fig. 1g and Supplementary Movies 3-5). The majority of premacrophages were trafficking in the YS bloodstream with an average velocity of about 210 µm/s, while some CX 3 CR1+ cells displayed slow surface translocation (rolling) at significantly lower mean velocity of 25 µm/s (Fig. 1j, k and Supplementary  Fig. 1h ). On occasion, pre-macrophages re-adhered transiently to YS endothelial structures after their vascular infiltration (Supplementary Movie 2). However, the biological meaning of these transient interactions remains unknown.
Restricted time window of vasculature-mediated infiltration. In vivo microscopy of the YS vasculature showed that CX 3 CR1+ cells appeared in the bloodstream shortly after the formation of a vascular network around E9 ( Fig. 1i and Supplementary Fig. 1e ) 7, 28 . Subsequently, we observed a rapid increase in intravascular premacrophages trafficking to the embryo up to a maximum of about 30 cells/min at E10.5 in an average-sized vessel of about 60 µm in diameter at this developmental stage ( Fig. 1i and Supplementary  Fig. 1f, g ). The highest number of pre-macrophages trafficking through the bloodstream per minute was observed between E9.5 and E10.5. At E12.5 the number dropped by more than 90% and no trafficking cells were observed at E14.5 (Fig. 1i , Supplementary Movies 3-5).
Yolk sac macrophages in humans. The process of hematopoietic development is conserved between mouse and humans 29 . In men, the YS serves as the initial site of hematopoiesis and gives rise to granulo-macrophage progenitors 30, 31 . We collected fetal material from week 9 of gestation to determine the phenotype of human YS macrophages. YS macrophages were spherical as their mouse counterparts, while mature macrophages in the placenta presented the typical morphology of mature phagocytes with multiple dendrites ( Supplementary Fig. 2a, b) . Besides the human macrophage markers macrosialin (CD68) and epidermal growth factor modulecontaining mucin-like receptor 2 (EMR2, CD312) 32, 33 , macrophages of the human YS expressed CX 3 CR1 as in mice (Supplementary Fig. 2a, b) . Thus, we identified similarities between mouse and human YS macrophages, opening the possibility of analogies in their development. The surface expression of EMR2 is of potential interest, since differential expression of EMR2 has been linked to macrophage maturation 33 .
Trafficking concurs with vascular network formation. YS CX 3 CR1+ pre-macrophages are located in close proximity to vascular structures ( Fig. 1f and Supplementary Fig. 1d ), which is consistent with histological reports 34, 35 . In the embryo, the primary target for YS-derived pre-macrophages was the developing brain, which is also characterized by the early establishment of a vascular network (Fig. 2a-f and Supplementary Movie 6) 8, 35 . Although some CX 3 CR1+ cells were found in close proximity to the brain vasculature, they distributed throughout the head region forming a dense cellular network (Fig. 2b , e and Supplementary Movie 6). The infiltration of other tissues started thereafter reaching comparable cell densities of about 80 CX 3 CR1+ cells/ microscopic field at E12.5 ( Fig. 2b-d) . Macrophage numbers in YS and embryonic tissues remained stable from E12.5, supporting the notion that infiltration of the embryo by tissue macrophage progenitors was mostly completed at this time.
Trafficking is restricted to spherical-shaped macrophages. Next we addressed whether alterations in cell morphology accompanying macrophage maturation were associated with macrophage trafficking. Pre-macrophages in the bloodstream displayed a spherical shape (Supplementary Movies 1-6 ). In contrast, dendrite-shaped YS macrophages did not enter the circulation or traveled through blood. The findings established with epifluorescence imaging were confirmed by high resolution spinning disc confocal microscopy in Cx 3 cr1 Cre :Rosa26 mT/mG embryos (Fig. 3a, b and Supplementary Movie 7). Thus, alterations in cell morphology correlate with restricted trafficking potential of YS macrophages. In line with this, large numbers of matured macrophages with dendrites remained in YS tissue after E12.5 (Fig. 1d, e, i) . Interestingly, respective macrophages with mature morphology extended their dendrites into the YS tissue and also into the vessel lumen (Fig. 3c-f and Supplementary Movie 8).
YS macrophage trafficking is independent of MYB and CX 3 CR1. Trafficking of pre-macrophages from the YS to the embryo took place mostly between E9.5 and E10.5, significantly decreased towards E12.5 and was not observed after E14.5 ( Fig. 1i) . This raised the possibility that pre-macrophage trafficking was restricted by the onset of fetal definitive hematopoiesis. HSCs arise in the AGM region from E10.5 and are found in the fetal liver by E12, where they produce hematopoietic cells 36 . We therefore revisited macrophage development in mice lacking fetal definitive hematopoiesis due to genetic absence of the transcription factor MYB (Fig. 4a, b) . From E9.5 through E16.5 CX 3 CR1+ cell numbers and densities in YS and embryonic tissues were not altered in the absence of HSCs and their progeny (Fig. 3c, d and Supplementary Fig. 3a-c) 8, 22 . Using intravital microscopy, we found that numbers and timing of premacrophage trafficking from the YS to the embryo in Myb knockout mice (Myb −/− :Cx 3 cr1 GFP/+ ) were comparable to wild type (Myb +/+ :Cx 3 cr1 GFP/+ ) littermates ( Fig. 4e and Supplementary Movies 9, 10). Thus, onset of fetal definitive hematopoiesis did not influence, or even restrict, pre-macrophage trafficking from the YS. These data also showed that most CX 3 CR1+ cells identified in tissues after the onset of fetal hematopoiesis were derived from YS hematopoiesis but not from MYB-dependent hematopoietic progenitors. This is noteworthy, because CX 3 CR1 is potentially expressed on various mature blood cells including fetal liver and BM monocytes 37 , which could have biased our analysis at later stages of embryonic development (i.e. from E12.5). Further, our findings support the notion that YS-derived tissue macrophages are independent of the transcription factor MYB, which is consistent with previous reports 8 .
The chemokine receptor CX 3 CR1 mediates myeloid cell trafficking in inflammation [38] [39] [40] and macrophage colonization of the mouse embryo occurs in a CX 3 CR1-dependent manner 21 . We therefore addressed whether pre-macrophage trafficking was modulated by CX 3 CR1. In E10.5 embryos we found an increased cell density in the YS of Cx 3 cr1 GFP/GFP mice, while cell densities in embryonic tissues were decreased at this stage of development as previously reported (Fig. 4f) 21 . However, the number of cells per minute trafficking from the YS to the embryo was similar between Cx 3 cr1 GFP/GFP (functional knockout) and Cx 3 cr1 GFP/+ littermates (Fig. 4g) . Further, the different hematopoietic lineages in the fetal liver were not altered by loss of one or both Cx 3 cr1 alleles ( Supplementary Fig. 3d-f) . Thus, the molecular cues restricting macrophage migration from the YS to the embryo remain to be determined.
Trafficking of CSF1R+ macrophage progenitors. The major source of YS CX 3 CR1+ pre-macrophages are EMPs 21 , and we have previously shown that they can be labeled using a CSF1R-driven fate mapping system 16 . To define the trafficking dynamics of CSF1R+ macrophage progenitors we first performed intravital microscopy in Csf1r Cre :Rosa26 eYFP embryos (Fig. 5a ). We observed a strong increase in YFP+ cells in YS and embryonic tissues during the early development with the spatiotemporal distribution pattern being comparable to that of CX 3 CR1+ premacrophages ( Fig. 5b-g ). It should be noted that EMPs have multilineage (i.e. erythroid, megakaryocyte and myeloid) potential 23, 41 , resulting in the labeling of other hematopoietic cells in addition to macrophages 16 . Importantly, CSF1R+ cells traveled with similar velocity to CX 3 CR1+ pre-macrophages in the YS vasculature and the maximum number of trafficking progenitors was reached between 9.5 and E10.5 in both models, thus showing similar trafficking dynamics ( While labeling of CSF1R-expressing cells is more efficient in mice with constitutively active Cre recombinase as compared to a tamoxifen (TAM)-inducible system, onset of fetal definitive hematopoiesis may lead to a bias during microscopy of YS macrophage trafficking. In order to label YS-derived CSF1R+ cells and their progeny before the onset of fetal definitive hematopoiesis 8 , we crossed Csf1r MerCreMer mice with a Rosa26 eYFP reporter and applied a single dose of 4-hydroxytamoxifen (OH-TAM) to induce expression of the yellow fluorescent protein (YFP) in a temporally-controlled manner ( Fig. 6a-g ). YFP labeling in E10.5 progenitors was low when OH-TAM was injected at E7.5, but increased about 6-fold when OH-TAM was injected at E8.5 ( Fig. 6b, c) , which is in line with previous reports that Csf1r becomes active during maturation 12, 16, 34 . E8.5 OH-TAM injection labeled about 10-20% erythrocytes, granulocytes and macrophages whereas cells of the lymphoid lineage were not labeled, which is consistent with EMP multilineage potential (Supplementary Fig. 4a-d) 16, 23 .
YFP+ cells were first detected in the YS at E8.5 after OH-TAM pulse labeling at E7.5. Approximately 12 h later, coinciding with the onset of circulation, CSF1R+ cells could be also detected in the embryo (Fig. 6d ). Trafficking kinetics of YFP+ cells in Csf1r MerCreMer :Rosa26 eYFP embryos OH-TAM-pulsed at E8.5 were comparable with that of Csf1r Cre :Rosa26 eYFP and Cx 3 cr1 GFP/+ embryos analyzed earlier ( Fig. 6g and Supplementary Movies 13, 14) . In general, infiltration of the embryo occurred mostly between E9.5 and E12.5 in these mice confirming that the trafficking of macrophages and their progenitors from the YS via the bloodstream was restricted to this well-defined time window of development (Fig. 6g) . The difference in the number of trafficking cells at E12.5 between pulse-labeled Csf1r MerCreMer (Figs 5 and 6f) and Cx 3 cr1 GFP/+ (Fig. 1i ) mice could reflect CSF1R-labeling of EMPs as compared to matured "primitive" macrophages, the latter having completed their emigration from the YS at this time.
To dissect the different stages of macrophage development in the YS, we harnessed Csf1r MerCreMer :Rosa26 tdTomato :Cx 3 cr1 GFP/+ mice, in which we combined the E8.5 CSF1R-mediated OH-TAM pulse labeling approach with the constitutive Cx 3 cr1 GFP/+ model to identify maturing macrophages. By E10.25/E10.5 a large proportion of CSF1R+ EMPs had acquired CX 3 CR1 (Fig. 6h,  Supplementary Fig. 4c ), which is in line with the recent reports on the sequence of macrophage maturation 12, 21 . CSF1R+ CX 3 CR1+ pre-macrophages displayed a spherical shape and were frequently found to be traveling to the embryo (Fig. 6h , Supplementary Movies 3-5 and 7). F4/80 was expressed on mature macrophages with dendrites. These cells were located throughout the YS and often adjacent to YS vessels. They displayed reduced migration capacity and did not travel intraluminally (Figs. 3, 6h and Supplementary Movies 7, 8) . Thus, trafficking of macrophage progenitors to the embryo correlated with defined stages of their development.
Expansion of CSF1R + macrophage progenitors. The proliferative potential of YS EMPs has previously been demonstrated in vitro using clonogenic assays 16 . In Csf1r MerCreMer :Rosa26 eYFP embryos in vivo, E8.5 OH-TAM pulse-labeled CSF1R+ progenitors displayed cell clusters in tissues (Fig. 6d, Fig. 6e, f) . This suggests that macrophage progenitors expand in the YS before their emergence and further expansion takes place inside the embryo. This is in line with the proliferation dynamics of YS-derived EMPs in the fetal liver 16 and of tissue macrophages in the epidermis of adult mice 42 . Notably, in liver sections of 1 year-old Csf1r MerCreMer :Rosa26 eYFP mice pulsed at E8.5, large clusters of YFP+ Kupffer cells were present (Fig. 6i, j) . Thus, the patterns of expansion initiated during early embryonic development can persist in adult mice. Future fate mapping experiments harnessing multicolor reporter mice are necessary to proof clonality of these cell clusters.
Trafficking dynamics of KIT + EMPs. Application of a OH-TAM pulse at E8.5 in Csf1r MerCreMer :Rosa26 eYFP embryos effectively labeled YS-derived EMPs ( Supplementary Fig. 4b ) 16, 43 . However, maturing macrophages that arise from the first (primitive) wave of YS hematopoiesis may also be labeled once Csf1r has become active 6, 44 . Flow cytometry analyses of the YS revealed a CD16/32 + KIT-population of primitive macrophages progenitors before the first appearance of EMPs suggesting their independent origin in line with previous reports (Supplementary Fig. 5a ) 12, 23 . Only a few hours later KIT+ EMPs develop in the YS and seed the fetal liver ( Supplementary Fig. 5a -d) before they differentiate into KIT-CX 3 CR1+ pre-macrophages as described previously (Supplementary Fig. 5b, e) 12, 23 . To more specifically determine the trafficking of YS-derived EMPs we carried out intravital microscopy in mice, in which Credependent recombination was under control of the Kit promoter. KIT has previously been identified as a marker of EMPs 12, 45 , and distinguishes them from maturing YS macrophages and primitive progenitors 22, 23 . In order to label KIT+ progenitors, we crossed Kit MerCreMer mice with Rosa26 mT/mG reporter mice and applied a single dose of OH-TAM to induce GFP expression (Fig. 7a) . In Kit MerCreMer :Rosa26 mT/mG embryos, OH-TAM application from E7.5 to E8.5 resulted in increased labeling of EMPs (Fig. 7b-d) . Intravital microscopy at E10.5 showed that numerous EMPs, or their progeny, migrated to the embryo via the YS vasculature (Fig. 7e, f and Supplementary Movie 15) . Cells derived from Kitexpressing progenitors thereby infiltrated all embryonic regions including the brain (Fig. 7b, c, g ). However, the number of trafficking cells in E8.5 pulse-labeled Kit MerCreMer embryos was lower than in E8.5 pulse-labeled Csf1r MerCreMer mice at E10.5, when trafficking reached its maximum (Figs. 6g and 7e) . The difference might be explained by labeling of both EMPs and differentiating "primitive" macrophages in the Csf1r-dependent model. However, other factors such as differences in Cre recombination efficiency might also play a role. In summary, the experiments indicate that of the different cell types labeled by applying a OH-TAM pulse, EMPs and their progeny represent an integral part trafficking from the YS to the embryo, which is in line with their role in seeding the fetal liver 13,16,46 .
Discussion
Our study provides a detailed characterization of early YS macrophage development and trafficking to embryonic tissues in high spatiotemporal resolution. Shortly after their appearance in the YS, macrophage progenitors-in both EMP and pre-macrophage stages-travel within the bloodstream to infiltrate the embryo. The trafficking process reaches a maximum around E10.5 and is mostly completed by E12.5. YS macrophages thereby traffic in spherical mobile shape. A dendrite-rich form is acquired by YSderived macrophage progenitors once target tissues have been reached and further maturation proceeds. Thus, alterations in cell morphology accompanying macrophage maturation correlate with their distribution through the bloodstream (Fig. 8) . However, the transition from round cells to dendritic macrophages could be happening independently of the trafficking process within tissues. By applying intravital microscopy we provided direct evidence that YS macrophage progenitors colonize the embryo via the vasculature. There has been an ongoing debate on how YS macrophages enter the embryo, that is, by trans-tissue migration or trans-vascular trafficking via the bloodstream. The early appearance of myeloid colony-forming units in embryonic blood before the onset of fetal definitive hematopoiesis indicates transvascular trafficking 13 . Further, infiltration of embryonic tissues by EMPs and maturing macrophages is impaired in mice lacking a heartbeat supporting the role of a functional circulation for macrophage trafficking 7,22,47,48,] . However, this model is limited by its dramatic impairment of overall mouse physiology resulting in early embryonic lethality 49 . In contrast to the data supporting trans-vascular migration, it has been suggested for various species that macrophages can colonize embryonic tissues independently of blood vessels via extravascular routes [25] [26] [27] 35 . In line with this, functional circulation is not required for EMP emergence in the YS 22 . We interpret our data to indicate that macrophage progenitors infiltrate the embryo predominantly by intravascular trafficking. However, the microscopy tools applied in this paper are suited for imaging fast intravital processes and, therefore, we cannot quantify nor exclude trans-tissue migration. Macrophage trafficking reached its maximum around E10.5, and we detected hardly any intravascular CX 3 CR1+ premacrophages after E12.5. Blood flow velocity in the YS vasculature still increases at this gestational age in mice. It is half maximal at E10.5 and does not reach a plateau before E13.5 50 . Therefore, flow velocity does not seem to relevantly contribute to the trafficking of macrophages to the embryo. Further, trafficking is not influenced by the onset of fetal definitive hematopoiesis as demonstrated in Myb-deficient mouse embryos. The absence of CX 3 CR1 chemokine receptor signaling resulted in higher macrophage densities in the YS and impaired colonization of the embryo 21 ; however, the quantity of intravascular cells was not altered. Thus, CX 3 CR1 does not affect intravascular trafficking of macrophage progenitors from the YS, it might however alter macrophage proliferation in the YS 51 or modulate survival in peripheral embryonic tissues 52, 53 , which remains to be determined. The molecular cues regulating macrophage trafficking from the YS to the embryo will need to be addressed in future studies. In addition to potential soluble molecules in the YS environment or cell surface receptors expressed on YS progenitors, endothelium-derived signals have recently been reported to modulate the seeding of macrophages in their destined tissue within the embryo 54 .
YS hematopoiesis gives rise to multipotent cells that can develop into fetal lymphoid progenitors [55] [56] [57] [58] . The EMPs and premacrophages progenitors pulse-labeled in Csf1r MerCreMer : Rosa26 eYFP embryos did not express markers of lymphoid cells. Although we did not carry out clonogenic assays and we therefore cannot formally exclude the lymphoid potential of trafficking CSF1R+ cells 22, 59 , our findings are in line with a recent study by McGrath and colleagues who phenotyped purified EMPs and demonstrated their lack of B-lymphoid potential 23 . Further, lineage tracing in Rag1 Cre :Rosa26 eYFP mice indicated that tissue macrophages develop independently of lymphoid-primed YS progenitors 59 .
Using intravital microscopy, we show that YS macrophage progenitors migrate to the embryo in both EMP and premacrophage stages. This is in line with the concept that EMPs travel to the embryo to colonize the nascent fetal liver before E10.5, where they give rise to tissue macrophages and other myeloid cells (Supplementary Fig. 4b ) 13, 16, 46 . The observation that more fluorescent cells were trafficking in E10.5 Csf1r MerCreMer embryos than in Kit MerCreMer mice might be explained by the labeling of both maturing macrophages derived from primitive hematopoiesis and EMPs in the CSF1R-dependent model, whereas pulse labeling in Kit MerCreMer embryos is more specific for fate mapping of EMPs 23 .
Most macrophage progenitors travel between E9.5 and E10.5; however first pre-macrophages enter the embryo around E9.0 with the onset of functional circulation. This population of macrophages predominantly infiltrates the embryonic brain (Figs. 2a-d and 5f , g and Supplementary Fig. 3a-c) . It is possible that these cells arise from the first wave of KIT-CD16/32+ primitive progenitors 6 . However, this population might be heterogeneous and additional markers to unequivocally identify primitive macrophages remain to be determined. In close temporal proximity, emerging EMPs give rise to an increasing pool of macrophage progenitors that seed all embryonic tissues. Depending on the organ environment, these YS-derived resident macrophages then persist (e.g. brain, liver) or are replaced by circulating monocytes, either rapidly (e.g. intestine) or over time (e.g. lung, serous cavities) 7,16,60-62,] . In summary, our study provides novel insights into the emergence of macrophage progenitors from the YS, a key process in the establishment of the innate immune system.
Methods
Mice. Cx 3 cr1 GFP/+ 37 , Cx 3 cr1 Cre 9 , Myb −/− 63 , Csf1r Cre expressing an improved Cre sequence under control of the Csf1r promoter 64 , TAM-inducible Csf1r MerCreMer 65 and Kit MerCreMer 66 , as well as Rosa26 eYFP 67 , Rosa26 mT/mG 68 and Rosa26 tdTomato 69 reporter mice have been previously described. Csf1r Cre and Csf1r MerCreMer were on FVB/N background, all other mice were on C57BL/6J background (backcrossed for at least 5 generations). Timed matings were carried out using 10-20 weeks old mice. Embryos were analyzed at indicated time points without determining their sex. Mice were maintained in a specific pathogen-free environment and fed standard mouse diet ad libitum. All animal procedures were performed in adherence to our project licence (55.2-1-54-2532-181-13) issued by the German regional council at the Government of Bavaria (Regierungspräsidium Oberbayern), Munich, Germany, and by the Institutional Review Board (IACUC 15-04-006) of the Memorial Sloan Kettering Cancer Center, New York, USA.
Timed matings and pulse labeling. Mice of desired genotypes were mated overnight. Embryonic development was estimated considering midday of the vaginal plug as embryonic day 0.5 (E0.5). Pregnant females were used for subsequent experiments on indicated time points. For genetic cell labeling, we crossed TAM-inducible Csf1r MerCreMer or Kit MerCreMer with Rosa26 eYFP or Rosa26 mT/mG . Recombination was induced in embryos by single injection of 75 µg per g (body weight) of 4-hydroxytamoxifen (Sigma) into pregnant females at indicated time points.
Intravital epifluorescence microscopy. Experiments were performed in deep anesthesia. Access to the abdominal cavity of pregnant mice was provided by a cesarean section. Depending on the developmental stage, intravital imaging was predominantly carried out in separation from the mother animal (E8.5-E12.5) for reasons of image quality or in continuous connection to the maternal circulation (E12.5-E16.5). Quantity and velocity of trafficking CX 3 CR1+ cells in separated E10.5 embryos was similar to embryos being in continuous connection to the mother ( Supplementary Fig. 1g, h ). Imaging of all embryos was performed in a heated environment in 37°C PBS with continuous temperature monitoring. Average sized vessels of the YS (Supplementary Fig. 1f ) were imaged using an Olympus BX51WI epifluorescence microscope with a Plan N 10x/0.25 or PlanApo N 1.25x/0.04 objective for 3-15 min in different areas of the YS or the embryo using the Olympus cell R imaging software. Maximum total imaging periods per YS were about 60 min. Vascular borders were identified by spontaneous image contrast in the GFP channel and confirmed by an intravital endothelial staining with a rat anti-CD31 (PECAM-1) antibody (clone MEC 13.3, Biolegend, 1:100) (Figs. 1f and 2e) . Cell clusters were defined as a cell-to-cell distance <2 cell diameters (Fig. 6f) . After imaging, mice were sacrificed and embryos were used for further analysis. Intravital spinning disc confocal microscopy. Experiments were performed in deep anesthesia. Embryos were prepared as described above for intravital epifluorescence microscopy. Analysis of YS-derived macrophage trafficking in realtime in vivo was performed in Cx 3 cr1 Cre :Rosa26 mT/mG embryos (E9.5, E10.5) using an upright spinning disk confocal microscope (Examiner, Zeiss, Germany) equipped with a confocal scanner unit CSU-X1 (Yokogawa Electric Corporation, Japan) and a CCD camera (Evolve, Photometrics, USA). Images were acquired with a 20x/ 1.0 NA or a 63x/ 1.0 NA water immersion objective (Plan Apochromat, Zeiss, Germany) using a laser with an excitation wavelength of 488 nm for the detection of macrophages and a laser with an excitation wavelength of 561 nm for the detection of the tomato fluorescence signal of all other tissues. Imaging and image processing was performed using Slidebook 6.0.11 Software (3i, USA) and Fiji (NIH, USA) 70 .
Antibodies for immunofluorescence. Human cryosections were stained with a primary mouse anti-CD68 antibody (clone CL1346, Sigma, 1:1000), rabbit anti-CD68 antibody (polyclonal, Sigma, 1:1000), rabbit anti-CX 3 CR1 (polyclonal, Abcam, 1:100), or rat anti-EMR2 (clone W15101A, Biolegend, 1:100), as well as a secondary goat-anti-mouse IgG Cy2 antibody (Jackson ImmunoResearch, 1:100), goat anti-rat IgG Cy3 (Dianova, 1:100), goat anti-rabbit IgG Cy2 (Dianova, 1:100), or goat anti-rabbit IgG Cy3 antibody (Dako, 1:100). Nuclei were stained using Vectashield mounting medium for fluorescence with DAPI (Vector Laboratories, 1.5 µg/ml).
Human samples and laser scanning confocal microscopy. Preparation and analysis of human material was approved by the Institution's ethics committee (reference #337-06 amended 26/08/2013). The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and written informed consent was obtained from each patient included in the study. Human samples were fixed in 4% neutral buffered formalin, dehydrated and consecutively embedded in paraffin. Blocks were sliced in 5 µm sections. Afterwards sample sections were washed and stained with indicated primary antibody for 60 min at room temperature and secondary antibodies for 30 min at room temperature. Confocal fluorescence images were obtained with a LSM880 Zeiss microscope with a 20x/0,8 dry objective and an Airyscan module. Images were acquired using ZEN software (Zeiss, Germany).
Analysis of mouse liver sections. Timed matings were performed as described above and Csf1r MerCreMer :Rosa26 eYFP embryos were pulse-labeled at E8.5. 1 year after birth, mice were euthanized under terminal anesthesia and livers were harvested. Organs were washed in PBS, fixed in 4% PFA and incubated in 30% sucrose overnight at 4°C. Samples were embedded in Tissue-Tek OCT (Sakura Finetek) and cryoblocks were sliced into 15 μm sections. Sections were incubated in PBS containing BSA (5%) and normal goat IgG (1:60). Primary antibodies were added overnight at 4°C. After washing, secondary antibodies were incubated for at least 2 h at room temperature. Nuclei were counterstained with DAPI. Sections were postfixed with PFA 1% for 1 min and mounted with mounting medium (Vector Laboratories). Acquisitions were performed using a Leica TCS SP5 confocal microscope (Leica Microsystems) with tile scan software and 10x/0.4 (dry) as well as 20x/0.7 (water immersion) objective.
Microscopy of mouse whole mount stainings. YSs were mounted and visualized using a Axio Imager.M2 microscope (Zeiss, Germany) with a 20x/0.75 Plan Apochromat or 40x/0.8 Plan Neofluar objective and AxioVision Software (Zeiss, Germany) (refers to data presented in Supplementary Fig. 1d, e) . Alternatively, a LSM880 Zeiss microscope with 40x/1.4 (oil) objective with ZEN black software (Zeiss, Germany) was used and data was analyzed with Imaris software (refers to data presented in Fig. 6g ).
Flow cytometry of mouse embryonic tissues. Pregnant females were sacrificed by cervical dislocation. Embryos ranging from embryonic day (E) 8.5 to E16.5 were dissected out from the uterus and washed in 4°C phosphate buffered saline (PBS, Invitrogen). The YS, fetal liver or embryonic regions (brain, trunk, tail) were harvested and digested in PBS containing 1 mg/ml Collagenase D (Roche), 100 U/ ml Desoxyribonuclease I (Sigma) and 1% fetal bovine serum (PAA Laboratories) at 37°C. Tissues were mechanically dissociated and passed through a 100 μm cell strainer (BD). Cells were centrifuged at 400 g for 5 min, resuspended in 4°C PBS, plated in multi-well round-bottom plates and immunolabeled for flow cytometry analysis. Antibody mixes were added in 1% BSA/PBS and incubated for 20 min on 4°C.
APC-Cy7-labeled anti-CD45.2 (clone 104) antibodies were from BD Pharmingen. Brilliant violet 421-labeled anti-F4/80 (clone BM8), APC-labeled anti-B220 (clone RA3-6B2), brilliant violet 421-labeled anti-CSF1R (CD115; clone AFS98), Alexa 647-labeled anti-CX 3 CR1 (clone SA011F11), PE-labeled anti-CD4 (clone H129.19), PE-labeled anti-CD19 (clone 6D5), APC-labeled anti-IL7Ra (CD127; clone A7R34), PE-labeled anti-Ter119 (clone Ter-119) and PE-labeled anti-CD16/32 (FcgRIII/II; clone 93) antibodies were from Biolegend. APC-labeled anti-KIT (CD117; clone 2B8) and PE-labeled anti-CD11b (clone M1/70) antibodies were from BD Biosciences. APC-labeled anti-Gr1 (Ly6G; clone RB6-8C5) antibodies were from eBiosciences. Flow cytometry was performed using a BD Biosciences LSR Fortessa flow cytometer and data were analyzed using FlowJo 10.
Statistics. Data were tested for normal distribution using the D'Agostino & Pearson omnibus test. In case of normal distribution, comparisons between groups were calculated using unpaired, two-tailed Student's t-test or one-way analysis of variance ANOVA (with Tukey's multiple comparisons test). If normal distribution was not given, Mann-Whitney test or Kruskal-Wallis test (with Dunn's multiple comparisons test) was used. A p-value of <0.05 was regarded as significant. Data is indicated as (***) p < 0.001, (**) p < 0.01, (*) p < 0.05, or not significant (n.s.) if p ≥ 0.05. Data are are expressed as mean ± standard deviation (SD) if normal, or as median with interquartile range (IQR) if not distributed normally. Dots represent individual values. All graphs and calculations were generated with GraphPad Prism 7 software.
Animal experiments were analyzed in a blinded manner where possible, i.e., when the genotype of the embryos was unknown at the time of experiments (analysis of Cx 3 cr1 GFP/+ vs. Cx 3 cr1 GFP/GFP , and Myb +/+ vs. Myb −/− mice).
Data availability. The authors declare that the data supporting the findings of this study are available within the article and its supplementary information files.
